Select Page
managed-Market_1

Maximize product access by channelizing all managed markets stakeholders

Ensure commercial success across the brand portfolio while maintaining affordable quality of care.

Managed markets

The journey of a drug from the manufacturing unit into the patients’ hands is a long and complicated one. Every life sciences company wants to ensure unfettered market access to meet commercial objectives while ensuring the desired patient benefits. To do so, companies must ensure that they work closely with each of the managed markets forces for optimized product coverage -> maximized market access -> desired patient and commercial outcomes.

Define the critical competitive advantage that could spell the difference between the real-world success or failure of life sciences products.

Managed-Market_2
Read Blog / What managed care analytics means to pharma brand success

Affecting patient’s access to desired treatments

Managed Market Forces

MANAGED MARKET FORCES Icon1

Commercial health plans and pharmacy benefit management (PBM)

MANAGED MARKET FORCES Icon2

Trade (wholesaler and specialty pharmacy)

MANAGED MARKET FORCES Icon3

Long-term care organizations

MANAGED MARKET FORCES Icon4

Institutional (hospitals and clinics)

MANAGED MARKET FORCES Icon5

Government (federal and state) provisions and reimbursements

Pharma Manufacturer icon circle

Pharma manufacturer

Big Arrow Green

Factors influencing a patient’s access to pharma products

Big Arrow Green

Factors influencing a patient’s access to pharma products

Big Arrow Green

Factors influencing a patient’s access to pharma products

Big Arrow Green

Factors influencing a patient’s access to pharma products

Patient icon circle

Patient

High-impact solutions offered